Eventide Asset Management, LLC Magenta Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$7.66 - $13.38 $7.66 Million - $13.4 Million	-1,000,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.1 - $7.94 $8.29 Million - $10.8 Million	-1,359,646 Reduced 57.62%	1,000,000 $7.84 Million
Q2 2020 Aug 14, 2020	BUY	$6.18 - $10.76 $3.52 Million - $6.13 Million	570,000 Added 31.85%	2,359,646 $17.7 Million
Q1 2020 May 15, 2020	SELL	$6.03 - $15.24 $9.67 Million - $24.4 Million	-1,604,248 Reduced 47.27%	1,789,646 $11.2 Million
Q4 2019 Jan 29, 2020	BUY	$9.07 - $15.84 $3.98 Million - $6.95 Million	438,462 Added 14.84%	3,393,894 $51.5 Million
Q3 2019 Nov 21, 2019	SELL	$9.63 - $14.0 $5.2 Million - $7.56 Million	-539,807 Reduced 15.44%	2,955,432 $30.3 Million
Q2 2019 Aug 14, 2019	BUY	$13.4 - $17.67 $5.7 Million - $7.51 Million	425,000 Added 13.84%	3,495,239 $50.8 Million
Q1 2019 May 15, 2019	BUY	$5.7 - $19.7 $2.39 Million - $8.26 Million	419,431 Added 15.82%	3,070,239 $49.7 Million
Q4 2018 Feb 14, 2019	BUY	$5.57 - $11.65 $2.3 Million - $4.81 Million	412,719 Added 18.44%	2,650,808 $14.8 Million
Q3 2018 Nov 14, 2018	BUY	$11.32 - $15.7 $11 - $15	1 Added 0.0%	2,238,089 $26.3 Million
Q2 2018 Aug 14, 2018	BUY	$13.5 - $14.52 $30.2 Million - $32.5 Million	2,238,088 New	2,238,088 $29.5 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.